Skip to main content
SpringerLink
Log in

Liver

  • Chapter
  • First Online:
ALERT • Adverse Late Effects of Cancer Treatment

Part of the book series: Medical Radiology ((Med Radiol Radiat Oncol))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 299.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

APR:

Acute phase reactant

AST:

Aspartate transaminase

ALT:

Alanine transaminase

ASGPR:

Asialoglycoprotein receptor

BUdR:

Bromodeoxyuridine

BMT:

Bone marrow transplantation

CTCAE:

Common terminology criteria for adverse events

CLIP:

Cancer of the liver Italian program

CT:

Computed tomographic

DVHs:

Dose–volume histograms

RBCs:

Erythrocytes

FUdR:

Fluorodeoxyuridine

GIT:

Gastrointestinal tract

GSH:

Glutathione

HBV:

Hepatitis B virus

HCC:

Hepatocellular carcinoma

HSC:

Hepatic stellate cell

ICG:

Indocyanine Green

IVC:

Inferior vena cava

IMRT:

Intensity modulated radiation therapy

IORT:

Intraoperative radiation therapy

NTCP:

Normal tissue complication probability

RILD:

Radiation-induced liver disease

RTOG:

Radiation Therapy Oncology Group

RHV:

Right hepatic vein

SECs:

Sinusoidal endothelial cells

SOS:

Sinusoidal obstructive syndrome

SMA:

Smooth muscle actin

SPECT:

Single-photon emission computerized tomography

SBRT:

Stereotactic body radiotherapy

TACE:

Transarterial chemo-embolization

TBI:

Total body irradiation

TGF-β:

Transforming growth factor-β

VOD:

Veno-occlusive disease

References

  • Abrams RA, Cardinale RM, Enger C et al (1997) Influence of prognostic groupings and treatment results in the management of unresectable hepatoma: experience with Cisplatinum-based chemoradiotherapy in 76 patients. Int J Radiat Oncol Biol Phys 39:1077–1085

    PubMed  CAS  Google Scholar 

  • Alati T, Van Cleeff M, Strom SC et al (1988) Radiation sensitivity of adult human parenchymal hepatocytes. Radiat Res 115:152–160

    PubMed  CAS  Google Scholar 

  • Alati T, Van Cleeff M, Jirtle RL (1989a) Radiosensitivity of parenchymal hepatocytes as a function of oxygen concentration. Radiat Res 118:488–501

    PubMed  CAS  Google Scholar 

  • Alati T, Eckl P, Jirtle RL (1989b) An in vitro micronucleus assay for determining the radiosensitivity of hepatocytes. Radiat Res 119:562–568

    PubMed  CAS  Google Scholar 

  • Amento EP, Beck LS (1991) TGF-beta and wound healing. Ciba Found Symp 157:115–123 discussion 123–129

    Google Scholar 

  • Anscher MS, Crocker IR, Jirtle RL (1990) Transforming growth factor-beta 1 expression in irradiated liver. Radiat Res 122:77–85

    PubMed  CAS  Google Scholar 

  • Anscher MS, Peters WP, Reisenbichler H et al (1993a) Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328:1592–1598

    PubMed  CAS  Google Scholar 

  • Anscher MS, Peters WP, Reisenbichler H, Petros WP, Jirtle RL (1993b) N Engl J Med 328:1592–1598

    PubMed  CAS  Google Scholar 

  • Austin-Seymour MM, Chen GT, Castro JR et al (1986) Dose volume histogram analysis of liver radiation tolerance. Int J Radiat Oncol Biol Phys 12:31–35

    PubMed  CAS  Google Scholar 

  • Bader TR, Herneth AM, Blaicher W et al (1998) Hepatic perfusion after liver transplantation: noninvasive measurement with dynamic single-section CT. Radiology 209:129–134

    PubMed  CAS  Google Scholar 

  • Barcellos-Hoff MH (2005a) How tissues respond to damage at the cellular level: orchestration by transforming growth factor-{beta} (TGF-{beta}). BJR Suppl 27:123–127

    PubMed  CAS  Google Scholar 

  • Barcellos-Hoff MH (2005b) Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage. Semin Cancer Biol 15:138–148

    PubMed  CAS  Google Scholar 

  • Barcellos-Hoff MH, Park C, Wright EG (2005) Radiation and the microenvironment—tumorigenesis and therapy. Nat Rev Cancer 5:867–875

    PubMed  CAS  Google Scholar 

  • Bearman SI (2001) Avoiding hepatic veno-occlusive disease: what do we know and where are we going? Bone Marrow Transplant 27:1113–1120

    PubMed  CAS  Google Scholar 

  • Bearman SI, Anderson GL, Mori M et al (1993) Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 11:1729–1736

    PubMed  CAS  Google Scholar 

  • Beetz A, Messer G, Oppel T et al (1997) Induction of interleukin 6 by ionizing radiation in a human epithelial cell line: control by corticosteroids. Int J Radiat Biol 72:33–43

    PubMed  CAS  Google Scholar 

  • Bjornsson E (2006) Drug-induced liver injury: Hy’s rule revisited. Clin Pharmacol Ther 79:521–528

    PubMed  Google Scholar 

  • Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358

    PubMed  CAS  Google Scholar 

  • Blomgren H, Lax I, Naslund I et al (1995) Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34:861–870

    Google Scholar 

  • Blomley MJ, Coulden R, Dawson P et al (1995) Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 19:424–433

    PubMed  CAS  Google Scholar 

  • Borgelt BB, Gelber R, Brady LW et al (1981) The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 7:587–591

    PubMed  CAS  Google Scholar 

  • Brooks SE, Miller CG, McKenzie K et al (1970) Acute veno-occlusive disease of the liver. Fine structure in Jamaican children. Arch Pathol 89:507–520

    PubMed  CAS  Google Scholar 

  • Bruno S, Maisonneuve P, Castellana P et al (2005) Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial. BMJ 330:932

    PubMed  PubMed Central  Google Scholar 

  • Burman C, Kutcher GJ, Emami B et al (1991) Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21:123–135

    PubMed  CAS  Google Scholar 

  • Cao Y, Pan C, Balter JM et al (2008) Liver function after irradiation based on computed tomographic portal vein perfusion imaging. Int J Radiat Oncol Biol Phys 70:154–160

    PubMed  PubMed Central  Google Scholar 

  • Carlini P, Papaldo P, Fabi A et al (2006) Liver toxicity after treatment with gefitinib and anastrozole: drug–drug interactions through cytochrome p450? J Clin Oncol 2006:60–61

    Google Scholar 

  • Castilla A, Prieto J, Fausto N (1991) Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 324:933–940

    PubMed  CAS  Google Scholar 

  • Chalandon Y, Roosnek E, Mermillod B et al (2004) Prevention of veno-occlusive disease with defibrotide after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 10:347–354

    PubMed  CAS  Google Scholar 

  • Cheng JC, Wu JK, Huang CM et al (2002) Radiation-induced liver disease after radiotherapy for hepatocellular carcinoma: clinical manifestation and dosimetric description. Radiother Oncol 63:41–45

    PubMed  Google Scholar 

  • Cheng JC, Wu JK, Huang CM et al (2003) Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease. Int J Radiat Oncol Biol Phys 56:229–234

    PubMed  Google Scholar 

  • Cheng JC, Liu MC, Tsai SY et al (2004a) Unexpectedly frequent hepatitis B reactivation by chemoradiation in postgastrectomy patients. Cancer 101:2126–2133

    PubMed  Google Scholar 

  • Cheng JC, Liu HS, Wu JK et al (2005) Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease. Int J Radiat Oncol Biol Phys 62:1150–1156

    PubMed  Google Scholar 

  • Chiba T, Tokuuye K, Matsuzaki Y et al (2005) Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients. Clin Cancer Res 11:3799–3805

    PubMed  Google Scholar 

  • Chou CH, Chen PJ, Lee PH et al (2007) Radiation-induced hepatitis B virus reactivation in liver mediated by the bystander effect from irradiated endothelial cells. Clin Cancer Res 13:851–857

    PubMed  CAS  Google Scholar 

  • Christiansen H, Sheikh N, Saile B et al (2007) X-irradiation in rat liver: consequent upregulation of hepcidin and downregulation of hemojuvelin and ferroportin-1 gene expression. Radiology 242:189–197

    PubMed  Google Scholar 

  • Coeman DC, Verbeken EK, Nackaerts KL et al (2000) A fatal case of cholestatic liver failure probably related to gemcitabine. Ann Oncol 11:1503

    PubMed  CAS  Google Scholar 

  • Concannon JP, Edelmann A, Frich JC Jr et al (1967) Localized “radiation hepatitis” as demonstrated by scintillation scanning. Radiology 89:136–139

    PubMed  CAS  Google Scholar 

  • Couinaud C (1992) Anatomie du foie. Ann Ital Chir 63:693–697

    PubMed  CAS  Google Scholar 

  • Couvelard A, Scoazec JY, Dauge MC et al (1996) Structural and functional differentiation of sinusoidal endothelial cells during liver organogenesis in humans. Blood 87:4568–4580

    PubMed  CAS  Google Scholar 

  • Davila M, Bresalier R (2008) Gastrointestinal complications of oncologic therapy. Nat Clin Pract Gastroenterol Hepatol 5:682–696

    PubMed  Google Scholar 

  • Dawson LA, Ten Haken RK (2005) Partial volume tolerance of the liver to radiation. Semin Radiat Oncol 15:279–283

    PubMed  Google Scholar 

  • Dawson LA, Brock KK, Kazanjian S et al (2001) The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy. Int J Radiat Oncol Biol Phys 51:1410–1421

    PubMed  CAS  Google Scholar 

  • Dawson LA, Eccles C, Bissonnette JP et al (2005a) Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys 62:1247–1252

    PubMed  Google Scholar 

  • DeLeve LD (1994) Dacarbazine toxicity in murine liver cells: a model of hepatic endothelial injury and glutathione defense. J Pharmacol Exp Ther 268:1261–1270

    PubMed  CAS  Google Scholar 

  • DeLeve LD (1996) Cellular target of cyclophosphamide toxicity in the murine liver: role of glutathione and site of metabolic activation. Hepatology 24:830–837

    PubMed  CAS  Google Scholar 

  • DeLeve LD (1998) Glutathione defense in non-parenchymal cells. Semin Liver Dis 18:403–413

    PubMed  CAS  Google Scholar 

  • DeLeve LD (2007) Hepatic microvasculature in liver injury. Semin Liver Dis 27:390–400

    PubMed  CAS  Google Scholar 

  • DeLeve LD, McCuskey RS, Wang X et al (1999) Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 29:1779–1791

    PubMed  CAS  Google Scholar 

  • DeLeve LD, Shulman HM, McDonald GB (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22:27–42

    PubMed  Google Scholar 

  • DeLeve LD, Wang X, Tsai J et al (2003) Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology 125:882–890

    PubMed  CAS  Google Scholar 

  • Donath D, Nori D, Turnbull A et al (1990) Brachytherapy in the treatment of solitary colrectal metastases to the liver. J Surg Oncol 44:55–61

    PubMed  CAS  Google Scholar 

  • Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122

    PubMed  CAS  Google Scholar 

  • Fajardo LF, Colby TV (1980) Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 104:584–588

    PubMed  CAS  Google Scholar 

  • Fedorocko P, Egyed A, Vacek A (2002) Irradiation induces increased production of haemopoietic and proinflammatory cytokines in the mouse lung. Int J Radiat Biol 78:305–313

    PubMed  CAS  Google Scholar 

  • Ganem G, Saint-Marc GMF, Kuentz M et al (1988) Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 14:879–884

    PubMed  CAS  Google Scholar 

  • Geraci JP, Mariano MS, Jackson KL (1991) Hepatic radiation injury in the rat. Radiat Res 125:65–72

    PubMed  CAS  Google Scholar 

  • Goin JE, Salem R, Carr BI et al (2005a) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol 16:195–203

    PubMed  Google Scholar 

  • Goin JE, Salem R, Carr BI et al (2005b) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16:205–213

    PubMed  Google Scholar 

  • Gourmelon P, Marquette C, Agay D et al (2005) Involvement of the central nervous system in radiation-induced multi-organ dysfunction and/or failure. BJR Suppl 27:62–68

    PubMed  CAS  Google Scholar 

  • Gray B, Hazel GV, Hope M et al (2001) Randomised trial of SIR-Spheres plus chemotherapy versus chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711–1720

    PubMed  CAS  Google Scholar 

  • Gushiken F (2000) Peliosis hepatis after treatment with 2-chloro-3′-deoxyadenosine. South Med J 93:625–626

    PubMed  CAS  Google Scholar 

  • Haddad E, LeBourgeois J, Kuentz M et al (1983) Liver complications in lymphomas treated with a combination of chemotherapy and radiotherapy: preliminary results. Int J Radiat Oncol Biol Phys 9:1313–1319

    PubMed  CAS  Google Scholar 

  • Hata M, Tokuuye K, Sugahara S et al (2006) Proton beam therapy for hepatocellular carcinoma with limited treatment options. Cancer 107:591–598

    PubMed  Google Scholar 

  • Herfarth KK, Debus J, Lohr F et al (2001) Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 19:164–170

    PubMed  CAS  Google Scholar 

  • Herfarth KK, Hof H, Bahner ML et al (2003) Assessment of focal liver reaction by multiphasic CT after stereotactic single-dose radiotherapy of liver tumors. Int J Radiat Oncol Biol Phys 57:444–451

    PubMed  Google Scholar 

  • Herfarth KK, Debus J, Wannenmacher M (2004) Stereotactic radiation therapy of liver metastases: update of the initial phase-I/II trial. Front Radiat Ther Oncol 38:100–105

    PubMed  Google Scholar 

  • Ho C, Davis J, Anderson F et al (2005) Side effects related to cancer treatment: case 1 Hepatitis following treatment with gefitinib. J Clin Oncol 23:8531–8533

    Google Scholar 

  • Hoefs JC, Chen PT, Lizotte P (2006) Noninvasive evaluation of liver disease severity. Clin Liver Dis 10:535–562, viii–ix

    Google Scholar 

  • Hosoi Y, Miyachi H, Matsumoto Y et al (2001) Induction of interleukin-1beta and interleukin-6 mRNA by low doses of ionizing radiation in macrophages. Int J Cancer 96:270–276

    PubMed  CAS  Google Scholar 

  • Hoyer M, Roed H, Traberg Hansen A et al (2006) Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 45:823–830

    PubMed  Google Scholar 

  • Iguchi T, Sato S, Kouno Y et al (2003) Comparison of Tc-99m-GSA scintigraphy with hepatic fibrosis and regeneration in patients with hepatectomy. Ann Nucl Med 17:227–233

    PubMed  Google Scholar 

  • Ingold J, Reed G, Kaplan H (1965) Radiation hepatitis. Am J Roentgenol 93:200–208

    CAS  Google Scholar 

  • Ishihara H, Tsuneoka K, Dimchev AB et al (1993) Induction of the expression of the interleukin-1 beta gene in mouse spleen by ionizing radiation. Radiat Res 133:321–326

    PubMed  CAS  Google Scholar 

  • Jackson A, Ten Haken RK, Robertson JM et al (1995) Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys 31:883–891

    PubMed  CAS  Google Scholar 

  • Jeffrey RB Jr, Moss AA, Quivey JM et al (1980) CT of radiation-induced hepatic injury. AJR Am J Roentgenol 135:445–448

    PubMed  Google Scholar 

  • Jirtle RL, Michalopoulos G, McLain JR et al (1981) Transplantation system for determining the clonogenic survival of parenchymal hepatocytes exposed to ionizing radiation. Cancer Res 41:3512–3518

    PubMed  CAS  Google Scholar 

  • Jirtle RL, McLain JR, Strom SC et al (1982) Repair of radiation damage in noncycling parenchymal hepatocytes. Br J Radiol 55:847–851

    PubMed  CAS  Google Scholar 

  • Jirtle RL, Michalopoulos G, Strom SC et al (1984) The survival of parenchymal hepatocytes irradiated with low and high LET radiation. Br J Cancer Suppl 6:197–201

    PubMed  CAS  PubMed Central  Google Scholar 

  • Jirtle R, Anscher M, Alati T (1990) Radiation sensitivity of the liver. Adv Radiat Biol 14:269–311

    Google Scholar 

  • Jungermann K (1988) Metabolic zonation of liver parenchyma. Semin Liver Dis 8:329–341

    PubMed  CAS  Google Scholar 

  • Kavanagh BD, Schefter TE, Cardenes HR et al (2006) Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 45:848–855

    PubMed  Google Scholar 

  • Kawashima M, Furuse J, Nishio T et al (2005) Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma. J Clin Oncol 23:1839–1846

    PubMed  Google Scholar 

  • Kennedy AS, Nutting C, Coldwell D et al (2004) Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60:1552–1563

    PubMed  CAS  Google Scholar 

  • Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412–425

    PubMed  CAS  Google Scholar 

  • Khalil N (1999) TGF-beta: from latent to active. Microbes Infect 1:1255–1263

    PubMed  CAS  Google Scholar 

  • Kim TH, Kim DY, Park JW et al (2007) Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 67:225–231

    PubMed  Google Scholar 

  • King PD, Perry MC (2001) Hepatotoxicity of chemotherapy. Oncologist 6:162–176

    PubMed  CAS  Google Scholar 

  • Kinzie J, Studer RK, Perez B et al (1972) Noncytokinetic radiation injury: anticoagulants as radioprotective agents in experimental radiation hepatitis. Science 175:1481–1483

    PubMed  CAS  Google Scholar 

  • Klinger M, Eipeldauer S, Hacker S et al (2009) Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoadjuvant XELOX/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol 35:515–520

    PubMed  CAS  Google Scholar 

  • Kopetz S, Vauthey JN (2008) Perioperative chemotherapy for resectable hepatic metastases. Lancet 371:963–965

    PubMed  Google Scholar 

  • Lawrence TS, Ten Haken RK, Kessler ML et al (1992) The use of 3-D dose volume analysis to predict radiation hepatitis. Int J Radiat Oncol Biol Phys 23:781–788

    PubMed  CAS  Google Scholar 

  • Lawrence TS, Robertson JM, Anscher MS et al (1995) Hepatic toxicity resulting from cancer treatment [Review] [64 refs]. Int J Radiat Oncol Biol Phys 31:1237–1248

    PubMed  CAS  Google Scholar 

  • Ley K (1996) Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 32:733–742

    PubMed  CAS  Google Scholar 

  • Lightdale CJ, Wasser J, Coleman M et al (1979) Anticoagulation and high dose liver radiation: a preliminary report. Cancer 43:174–181

    PubMed  CAS  Google Scholar 

  • Linard C, Ropenga A, Vozenin-Brotons MC et al (2003) Abdominal irradiation increases inflammatory cytokine expression and activates NF-kappaB in rat ileal muscularis layer. Am J Physiol Gastrointest Liver Physiol 285:G556–G565

    PubMed  CAS  Google Scholar 

  • Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390

    PubMed  CAS  Google Scholar 

  • Lyman JT (1985) Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8:S13–S19

    PubMed  CAS  Google Scholar 

  • Materne R, Van Beers BE, Smith AM et al (2000) Non-invasive quantification of liver perfusion with dynamic computed tomography and a dual-input one-compartmental model. Clin Sci (Lond) 99:517–525

    CAS  Google Scholar 

  • Meeren AV, Bertho JM, Vandamme M et al (1997) Ionizing radiation enhances IL-6 and IL-8 production by human endothelial cells. Mediators Inflamm 6:185–193

    PubMed  CAS  PubMed Central  Google Scholar 

  • Mehendale HM (2005) Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol 33:41–51

    PubMed  CAS  Google Scholar 

  • Mendez RA, Wunderink W, Hussain SM et al (2006) Stereotactic body radiation therapy for primary and metastatic liver tumors: a single institution phase i–ii study. Acta Oncol 45:831–837

    Google Scholar 

  • Miles KA (1991) Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol 64:409–412

    PubMed  CAS  Google Scholar 

  • Miles KA, Hayball M, Dixon AK (1991) Colour perfusion imaging: a new application of computed tomography. Lancet 337:643–645

    PubMed  CAS  Google Scholar 

  • Miles KA, Hayball MP, Dixon AK (1993) Functional images of hepatic perfusion obtained with dynamic CT. Radiology 188:405–411

    PubMed  CAS  Google Scholar 

  • Moriconi F, Christiansen H, Raddatz D et al (2008) Effect of radiation on gene expression of rat liver chemokines: in vivo and in vitro studies. Radiat Res 169:162–169

    PubMed  CAS  Google Scholar 

  • Neff R, Abdel-Misih R, Khatri J et al (2008) The toxicity of liver directed yttrium-90 microspheres in primary and metastatic liver tumors. Cancer Invest 26:173–177

    PubMed  CAS  Google Scholar 

  • Ogata K, Hizawa K, Yoshida M et al (1963) Hepatic injury following irradiation–a morphologic study. Tokushima J Exp Med 43:240–251

    PubMed  CAS  Google Scholar 

  • Ogawa Y, Murata Y, Nishioka A et al (1998) Tamoxifen-induced fatty liver in patients with breast cancer. Lancet 351:725

    PubMed  CAS  Google Scholar 

  • Ohara K, Okumura T, Tsuji H et al (1997) Radiation tolerance of cirrhotic livers in relation to the preserved functional capacity: analysis of patients with hepatocellular carcinoma treated by focused proton beam radiotherapy. Int J Radiat Oncol Biol Phys 38:367–372

    PubMed  CAS  Google Scholar 

  • Order S, Donaldson S (2003) Hemangiomas, radiation therapy of benign diseases—a clinical guide, 2nd edn. Springer, Berlin, pp 133–134

    Google Scholar 

  • Ostapowicz G, Fontana RJ, Schiodt FV et al (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137:947–954

    PubMed  Google Scholar 

  • Park HC, Seong J, Han KH et al (2002) Dose-response relationship in local radiotherapy for hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 54:150–155

    PubMed  Google Scholar 

  • Pawlik TM, Olino K, Gleisner AL et al (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11:860–868

    PubMed  Google Scholar 

  • Perez C, Korba A, Zivnuska F et al (1978) 60Co moving strip technique in the management of the ovary: analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys 4:279–388

    Google Scholar 

  • Peters AM, Brown J, Hartnell GG et al (1987a) Non-invasive measurement of renal blood flow with 99mTc DTPA: comparison with radiolabelled microspheres. Cardiovasc Res 21:830–834

    PubMed  CAS  Google Scholar 

  • Peters AM, Gunasekera RD, Lavender JP et al (1987b) Noninvasive measurement of renal blood flow using DTPA. Contrib Nephrol 56:26–30

    PubMed  CAS  Google Scholar 

  • Phillips R, Karnofsku D, Hamilton L et al (1954) Roentgen therapy of hepatic metastases. Am J Roengenol 71:826

    CAS  Google Scholar 

  • Rahmouni A, Montazel JL, Golli M et al (1992) Unusual complication of liver irradiation: acute thrombosis of a main hepatic vein: CT and MR imaging features. Radiat Med 10:163–166

    PubMed  CAS  Google Scholar 

  • Ramadori G, Armbrust T (2001) Cytokines in the liver. Eur J Gastroenterol Hepatol 13:777–784

    PubMed  CAS  Google Scholar 

  • Rappaport AM (1976) The microcirculatory acinar concept of normal and pathological hepatic structure. Beitrage zur Pathologie 157:215–243

    PubMed  CAS  Google Scholar 

  • Reiss U, Cowan M, McMillan A et al (2002) Hepatic venoocclusive disease in blood and bone marrow transplantation in children and young adults: incidence, risk factors, and outcome in a cohort of 241 patients. J Pediatr Hematol Oncol 24:746–750

    PubMed  Google Scholar 

  • Ricke J, Wust P, Stohlmann A et al (2004) CT-guided interstitial brachytherapy of liver malignancies alone or in combination with thermal ablation: phase I-II results of a novel technique. Int J Radiat Oncol Biol Phys 58:1496–1505

    PubMed  Google Scholar 

  • Robinson K, Lambiase L, Li J et al (2003) Fatal cholestatic liver failure associated with gemcitabine therapy. Dig Dis Sci 48:1804–1808

    PubMed  Google Scholar 

  • Rodriguez-Frias EA, Lee WM (2007) Cancer chemotherapy II: atypical hepatic injuries. Clin Liver Dis 11:663–676, viii

    Google Scholar 

  • Rollins BJ (1986) Hepatic veno-occlusive disease. Am J Med 81:297–306

    PubMed  CAS  Google Scholar 

  • Rosenthal J, Sender L, Secola R et al (1996) Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation. Bone Marrow Transplant 18:185–191

    PubMed  CAS  Google Scholar 

  • Rubin P, Levitt SH (1964) The response of disseminated reticulum cell sarcoma to the intravenous injection of colloidal radioactive gold. J Nucl Med Off Publ Soc Nucl Med 5:581–594

    CAS  Google Scholar 

  • Russell AH, Clyde C, Wasserman TH et al (1993) Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol. Int J Radiat Oncol Biol Phys 27:117–123

    PubMed  CAS  Google Scholar 

  • Saif MW (2008) Hepatic failure and hepatorenal syndrome secondary to erlotinib. Safety reminder. J Pancreas 9:748–752

    Google Scholar 

  • Sartori MT, Spiezia L, Cesaro S et al (2005) Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population. Thromb Haemost 93:682–689

    PubMed  CAS  Google Scholar 

  • Schacter L, Crum E, Spitzer T et al (1986) Fatal radiation hepatitis: a case report and review of the literature. Gynecol Oncol 24:373–380

    PubMed  CAS  Google Scholar 

  • Schefter TE, Kavanagh BD, Timmerman RD et al (2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62:1371–1378

    PubMed  Google Scholar 

  • Sempoux C, Horsmans Y, Geubel A et al (1997) Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: activation of hepatic stellate cells as an early event. Hepatology 26:128–134

    PubMed  CAS  Google Scholar 

  • Seong J, Park HC, Han KH et al (2003) Clinical results and prognostic factors in radiotherapy for unresectable hepatocellular carcinoma: a retrospective study of 158 patients. Int J Radiat Oncol Biol Phys 55:329–336

    PubMed  Google Scholar 

  • Seong J, Shim SJ, Lee IJ et al (2007) Evaluation of the prognostic value of Okuda, cancer of the liver Italian program, and Japan integrated staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 67:1037–1042

    PubMed  Google Scholar 

  • Sessa C, Aamdal S, Wolff I et al (1994) Gemcitabine in patients with advanced malignant melanoma or gastric cancer: phase II studies of the EORTC Early Clinical Trials Group. Ann Oncol 5:471–472

    PubMed  CAS  Google Scholar 

  • Shulman HM, McDonald GB, Matthews D et al (1980) An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. Gastroenterology 79:1178–1191

    PubMed  CAS  Google Scholar 

  • Shulman HM, Gown AM, Nugent DJ (1987) Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules. Am J Pathol 127:549–558

    PubMed  CAS  PubMed Central  Google Scholar 

  • Shulman HM, Fisher LB, Schoch HG et al (1994) Veno-occlusive disease of the liver after marrow transplantation: histological correlates of clinical signs and symptoms. Hepatology 19:1171–1181

    PubMed  CAS  Google Scholar 

  • Simon M, Hahn T, Ford LA et al (2001) Retrospective multivariate analysis of hepatic veno-occlusive disease after blood or marrow transplantation: possible beneficial use of low molecular weight heparin. Bone Marrow Transplant 27:627–633

    PubMed  CAS  Google Scholar 

  • Sindelar WF, Tepper J, Travis EL (1982) Tolerance of bile duct to intraoperative irradiation. Surgery 92:533–540

    PubMed  CAS  Google Scholar 

  • Speeg KV, Bay MK (1995) Prevention and treatment of drug-induced liver disease. Gastroenterol Clin North Am 24:1047–1064

    PubMed  CAS  Google Scholar 

  • Stubbs RS, Cannan RJ, Mitchell AW (2001) Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 48:333–337

    PubMed  CAS  Google Scholar 

  • Tabbara IA, Zimmerman K, Morgan C et al (2002) Allogeneic hematopoietic stem cell transplantation: complications and results. Arch Intern Med 162:1558–1566

    PubMed  Google Scholar 

  • Ten Haken RK, Martel MK, Kessler ML et al (1993) Use of Veff and iso-NTCP in the implementation of dose escalation protocols. Int J Radiat Oncol Biol Phys 27:689–695

    PubMed  Google Scholar 

  • Ten Haken RK, Lawrence TS, Dawson LA (2006) Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma: in regards to Xu et al. (Int J Radiat Oncol Biol Phys 65:189–195). Int J Radiat Oncol Biol Phys 66:1272; author reply 1272–1273, 2006

    Google Scholar 

  • Thomas DS, Nauta RJ, Rodgers JE et al (1993) Intraoperative high-dose rate interstitial irradiation of hepatic metastases from colorectal carcinoma. Results of a phase I-II trial. Cancer 71:1977–1981

    PubMed  CAS  Google Scholar 

  • Tian JH, Xu BX, Zhang JM et al (1996) Ultrasound-guided internal radiotherapy using yttrium-90-glass microspheres for liver malignancies. J Nucl Med 37:958–963

    PubMed  CAS  Google Scholar 

  • Todoroki T (1978) The late effects of single massive iradiation with electrons of the liver hilum of rabbits. Jpn J Gastrioentereol Surg 11:169–177

    Google Scholar 

  • Tsai SL, Chen PJ, Lai MY et al (1992) Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 89:87–96

    PubMed  CAS  PubMed Central  Google Scholar 

  • Tse RV, Hawkins M, Lockwood G et al (2008) Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma. J Clin Oncol 26:657–664

    PubMed  Google Scholar 

  • Uematsu M, Shioda A, Suda A et al (2000) Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit. Int J Radiat Oncol Biol Phys 48:443–448

    PubMed  CAS  Google Scholar 

  • Unger EC, Lee JK, Weyman PJ (1987) CT and MR imaging of radiation hepatitis. J Comput Assist Tomogr 11:264–268

    PubMed  CAS  Google Scholar 

  • Vauthey JN, Pawlik TM, Ribero D et al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24:2065–2072

    PubMed  CAS  Google Scholar 

  • Welsh JS, Kennedy AS, Thomadsen B (2006) Selective internal radiation therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 66:S62–S73

    PubMed  CAS  Google Scholar 

  • Welsh FK, Tilney HS, Tekkis PP et al (2007) Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 96:1037–1042

    PubMed  CAS  PubMed Central  Google Scholar 

  • Wharton JT, Delclos L, Gallager S et al (1973) Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 117:73–80

    PubMed  CAS  Google Scholar 

  • Wu DH, Liu L, Chen LH (2004) Therapeutic effects and prognostic factors in three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 10:2184–2189

    PubMed  Google Scholar 

  • Xu ZY, Liang SX, Zhu J et al (2006) Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma. Int J Radiat Oncol Biol Phys 65:189–195

    PubMed  Google Scholar 

  • Yaes RJ, Kalend A (1988) Local stem cell depletion model for radiation myelitis. Int J Radiat Oncol Biol Phys 14:1247–1259

    PubMed  CAS  Google Scholar 

  • Yamada K, Izaki K, Sugimoto K et al (2003) Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys 57:113–119

    PubMed  Google Scholar 

  • Yeo W, Chan PK, Zhong S et al (2000) Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors. J Med Virol 62:299–307

    PubMed  CAS  Google Scholar 

  • Zorzi D, Laurent A, Pawlik TM et al (2007) Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 94:274–286

    PubMed  CAS  Google Scholar 

Recommended Reading

  • Cheng JC, Wu JK, Lee PC et al (2004b) Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease. Int J Radiat Oncol Biol Phys 60:1502–1509

    PubMed  Google Scholar 

  • Dawson LA, Normolle D, Balter JM et al (2002) Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53:810–821

    PubMed  Google Scholar 

  • Dawson LA, Biersack M, Lockwood G et al (2005b) Use of principal component analysis to evaluate the partial organ tolerance of normal tissues to radiation. Int J Radiat Oncol Biol Phys 62:829–837

    PubMed  Google Scholar 

  • Liang SX, Zhu XD, Xu ZY et al (2006) Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance. Int J Radiat Oncol Biol Phys 65:426–434

    PubMed  Google Scholar 

  • Pan C, Kavanagh B, Dawson L et al (2008) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys

    Google Scholar 

  • Reed G, Cox A (1966) The human liver after radiation injury. A form of veno-occlusive disease. Am J Pathol 48:597–611

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

Thanks to Dr Mark Lee and Dr. Catherine Coolens for their thoughtful comments on this chapter.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, ON M5G 2M9, Canada

    Laura A. Dawson

  2. Department of Pathology (Rm. 11E210), University of Toronto, Toronto General Hospital, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada

    Oyedele Adeyi

  3. Department of Medical Oncology, Waterford Regional Hospital, Waterford, Ireland

    Anne Horgan

  4. Department of Radiation Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210 Street, Bronx, NY, 10467, USA

    Chandan Guha

Authors
  1. Laura A. Dawson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oyedele Adeyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Anne Horgan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chandan Guha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura A. Dawson .

Editor information

Editors and Affiliations

  1. Dept. Radiation Oncology, University of Rochester Medical Center James P. Wilmot Cancer Ctr., Rochester, New York, USA

    Philip Rubin

  2. Department of Radiation Oncology, University of Rochester Medical Center James P. Wilmot Cancer Ctr., Rochester, New York, USA

    Louis S. Constine

  3. Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina, USA

    Lawrence B. Marks

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dawson, L.A., Adeyi, O., Horgan, A., Guha, C. (2014). Liver. In: Rubin, P., Constine, L., Marks, L. (eds) ALERT • Adverse Late Effects of Cancer Treatment. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75863-1_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-75863-1_15

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-75862-4

  • Online ISBN: 978-3-540-75863-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation